PubMed · 1999 · 141 citations · 14 references
Life SciencesImmunologyPathologyImmunoregulationImmunotherapyTransplant ImmunologyAdaptive Immune ModulationAllograft RejectionHelper T Cell SubsetsImmunosuppressive TherapyTransplant ImmunotherapyTransplant RejectionAllograft Rejection MechanismsCd8 Positive T CellsImmunologic Response To AllograftT Cell - Mediated RejectionT Cell Costimulatory PathwaysT Cell Cytokine ProductionT-cell Mediated RejectionTh2 Immune Response
The effect of blocking the CD28/B7 costimulatory pathway on intestinal allograft rejection was examined in mice. Murine CTLA4Ig failed to prevent the rejection of allografts transplanted into wild-type or CD4 knockout (KO) mice but did inhibit allograft rejection by CD8 KO recipients. This effect was associated with decreased intragraft mRNA for IFN-gamma and TNF-alpha and increased mRNA for IL-4 and IL-5. This altered pattern of cytokine production was not observed in allografts from murine CTLA4Ig-treated CD4 KO mice. These data demonstrate that blockade of the CD28/B7 pathway has different effects on intestinal allograft rejection mediated by CD4+ and CD8+ T cells and suggest that these T cell subsets have different costimulatory requirements in vivo. The results also suggest that the inhibition of CD4+ T cell-mediated allograft rejection by CTLA4Ig may be related to down-regulation of Th1 cytokines and/or up-regulation of Th2 cytokines.
14
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Christian P. Larsen, Eric T. Elwood, Diane Z. Alexander et al. · Nature · 1996 · 1.5K citations